These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29689343)

  • 1. Leveraging genetics to enhance the efficacy of PTSD pharmacotherapies.
    Miller MW
    Neurosci Lett; 2020 May; 726():133562. PubMed ID: 29689343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant pharmacogenetics in children and young adults: A systematic review.
    Maruf AA; Greenslade A; Arnold PD; Bousman C
    J Affect Disord; 2019 Jul; 254():98-108. PubMed ID: 31112844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies.
    Zhang W; Davidson JR
    Expert Opin Pharmacother; 2007 Aug; 8(12):1861-70. PubMed ID: 17696789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.
    Sullivan PW; Valuck R; Saseen J; MacFall HM
    CNS Drugs; 2004; 18(13):911-32. PubMed ID: 15521793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy for post-traumatic stress disorder: a comprehensive review.
    Davis LL; English BA; Ambrose SM; Petty F
    Expert Opin Pharmacother; 2001 Oct; 2(10):1583-95. PubMed ID: 11825301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant treatment of posttraumatic stress disorder.
    Pearlstein T
    J Clin Psychiatry; 2000; 61 Suppl 7():40-3. PubMed ID: 10795608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis.
    Hoskins M; Pearce J; Bethell A; Dankova L; Barbui C; Tol WA; van Ommeren M; de Jong J; Seedat S; Chen H; Bisson JI
    Br J Psychiatry; 2015 Feb; 206(2):93-100. PubMed ID: 25644881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considering future pharmacotherapy for PTSD.
    Friedman MJ; Bernardy NC
    Neurosci Lett; 2017 May; 649():181-185. PubMed ID: 27890743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapies for Posttraumatic Stress Disorder: A Meta-Analysis.
    Gu W; Wang C; Li Z; Wang Z; Zhang X
    J Nerv Ment Dis; 2016 May; 204(5):331-8. PubMed ID: 26894318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertralilne, paroxetine and venlafaxine in refugee post traumatic stress disorder with depression symptoms.
    Smajkić A; Weine S; Durić-Bijedić Z; Boskailo E; Lewis J; Pavković I
    Med Arh; 2001; 55(1 Suppl 1):35-8. PubMed ID: 11795192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism.
    Preskorn SH
    Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to venlafaxine in a previously antidepressant treatment-resistant combat veteran with post-traumatic stress disorder.
    Hamner MB; Frueh BC
    Int Clin Psychopharmacol; 1998 Sep; 13(5):233-4. PubMed ID: 9817630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the pharmacogenetics of selective serotonin reuptake inhibitors.
    Fabbri C; Minarini A; Niitsu T; Serretti A
    Expert Opin Drug Metab Toxicol; 2014 Aug; 10(8):1093-118. PubMed ID: 24930681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin Transporter Gene Polymorphisms and Selective Serotonin Reuptake Inhibitor Tolerability: Review of Pharmacogenetic Evidence.
    Zhu J; Klein-Fedyshin M; Stevenson JM
    Pharmacotherapy; 2017 Sep; 37(9):1089-1104. PubMed ID: 28654193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for posttraumatic stress disorder: empirical review and clinical recommendations.
    Cooper J; Carty J; Creamer M
    Aust N Z J Psychiatry; 2005 Aug; 39(8):674-82. PubMed ID: 16050921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of pharmacotherapy for PTSD: an effect size analysis of controlled studies.
    Penava SJ; Otto MW; Pollack MH; Rosenbaum JF
    Depress Anxiety; 1996-1997; 4(5):240-2. PubMed ID: 9167791
    [No Abstract]   [Full Text] [Related]  

  • 19. PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS.
    Lee DJ; Schnitzlein CW; Wolf JP; Vythilingam M; Rasmusson AM; Hoge CW
    Depress Anxiety; 2016 Sep; 33(9):792-806. PubMed ID: 27126398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of selective serotonin reuptake inhibitors-selective serotonin norepinephrine reuptake inhibitors pharmacogenetics during pregnancy and lactation.
    Koren G; Ornoy A
    Pharmacogenomics; 2018 Sep; 19(14):1139-1145. PubMed ID: 30105921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.